The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fedorova N.V.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Iablonskaia A.Iu.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia

Bel'gusheva M.É.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia

Levodopa medications in the treatment of Parkinsons disease

Authors:

Fedorova N.V., Iablonskaia A.Iu., Bel'gusheva M.É.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(5): 30‑36

Read: 25549 times

Download PDF (RU)
Contact the author
Table of contents

LEVODOPA MEDICATIONS IN THE TREATMENT OF PARKINSONS DISEASE
LEVODOPA MEDICATIONS IN THE TREATMENT OF PARKINSONS DISEASE

To cite this article:

Fedorova NV, Iablonskaia AIu, Bel'gusheva MÉ. Levodopa medications in the treatment of Parkinsons disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(5):30‑36. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
The effect of bila­teral subthalamic nucleus deep brain stimulation on gait and bala­nce in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):94-101
Neuroinflammatory and neurodegenerative aspe­cts of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):102-111
Abstract:

There are many medications presently available for management of Parkinsons disease. Levodopa is the most effective one. Pharmacotherapeutic efficacy of some forms of drug is not similar due to differences in composition (inactive ingredients, excipients, preservatives, colorants). Authors carried out an open labeled comparative study of pharmacotherapeutic efficacy of the original drug - nakom and the generic one - tidomed (both drugs include levodopa and carbidopa). The improvement as assessed by the UPDRS-3 was seen in patients receiving nakom de novo. The significant reduction of motor deficit and increase of daily activity and duration of action of a single dose were noted in patients with motor fluctuations treated with nakom.

Keywords:

Parkinsons disease
levodopa
nakom

Authors:

Fedorova N.V.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Iablonskaia A.Iu.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia

Bel'gusheva M.É.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia

Close metadata

References:

  1. Vertkin A.L., Talibov O.B. Generiki i ekvivalentnost' - chto stoit za terminami. Neotlozhnaya terapiya 2004; 1-2: 16-17.
  2. Shtok V.N., Fedorova N.V. Lechenie parkinsonizma. M 1997; 196.
  3. OSullivan S.S., Evans A.H., Lees A.J. Dopamine dysregulation syndrome. An overview of its epidemiology, mechanisms and management. CNS Drugs 2009; 23: 2: 157-170.
  4. Caspar P., Duyckaens C. et al. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinsons disease. Ann Neurology 1991; 30: 365-374.
  5. Clarke C.E., Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinsons disease. J Neurol Neurosurg Psychiatry 2000; 69: 5: 590-594.
  6. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
  7. Fahn S., Eiton R. Unified Parkinsons disease rating scale. Recent developments in Parkinsons disearse. Eds. Fahn S., Marsden C., Calne D. et al. McMillan Healthcare Information 1987; 5: 153-163.
  8. Fan S., Oakes D., Shoulson I. et al. Parkinson Study Group. Levodopa and the progression of Parkinsons disease. N Engl J Med 2004; 351: 2498-2508.
  9. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: a practical guide for grading the mental state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
  10. Hoehn M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
  11. Hoehn M.M. The natural history of Parkinsons disease in the pre-levodopa and post-levodopa eras. Neurol Clin 1992; 10: 2: 331-339.
  12. Koller W.C., Tse W. Unmet medical needs in Parkinsons disease. Neurology 2004; 62: 17-22.
  13. Kummer A., Maia D.P., Salgado J.V. et al. Dopamine dysregulation syndrome in Parkinsons disease: case report. Arq Neuropsiquiatr 2006; 64: 4: 1019-1022.
  14. Kurlan R. "Levodopa phobia". A new iatrogenic cause of disability in Parkinsons disease. Neurology 2005; 64: 5: 923-924.
  15. Markham C.H., Diamond S.G. Evidence to support early levodopa therapy in Parkinsons disease. Neurology 1981; 31: 125-131.
  16. Nutt J.G., Wooten G.F. Clinical practice. Diagnosis and initial management of Parkinsons disease. N Engl J Med 2005; 353: 10: 1021-1027.
  17. Olanow C.W., Koller W.C. An algorithm (decision tree) for the management of Parkinsons disease: treatment guidelines. Neurology 1998; 50: 3: 27-30.
  18. Olanov C.W., Agid Y., Mizuno Y. et al. Levodopa in the treatment of Parkinsons disease: curent controversies. Mov Disord 2004; 19: 9: 997.
  19. Quinn N.P. Classification of fluctuations in patients with Parkinsons disease. Neurology 1998; 51: 25-29.
  20. Rajput A.H. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism and related disorders 2001; 8: 95-100.
  21. Rajput A.H., Fenton M.E., Birdi S. et al. Clinical-patological study of levodopa complications. Mov Dis 2002; 17: 289-296.
  22. Stacy M. et al. Wearing-off Questionnaire. Clinical Neuropharmacology 2006; 26: 6: 312-321.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.